Thursday, May 19, 2016

BRIEF-Tonix Pharmaceuticals reports positive topline results from phase 2 study of TNX-102 SL

* Tonix pharmaceuticals reports positive topline results

from phase 2 atease study of TNX-102 SL in post-traumatic stress

disorder (PTSD)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)